AIDS Cocktail Resistance Grows in San Francisco

Article

SAN FRANCISCO-Researchers from the University of California recently published an article in the journal Nature Medicine estimating that 42% of HIV infections in the Bay area will be resistant to current AIDS drugs by 2005.

This percentage has steadily increased since 1996. In 1999, 28.5% of AIDS cases were resistant to current technologies. The predicted percentage is continuing to fuel the race to discover new pharmaceuticals and treatment options for those infected.

Within the same research, the report states that mutant viral strains resistant to AIDS drugs are actually less dangerous that their wild counterparts. It typically takes and AIDS patient three years to lose the T-cells they gained from antiviral therapy.

Sally Blower, a UCLA biomathematician, is responsible for the prediction. Blower, using a computer program she developed, bases her infection system on her previous research in determining the risk of nuclear plant meltdowns. She has been using her infection prediction software for a decade. It does not, however, take into account the possibility of transmission of drug-resistant strains to those already infected with the virus.

With the report, researchers are expected to refocus on methods of reducing drug resistance and developing new therapies for those already infected with drug-resistant strains.

Researchers estimate there are 18,000 people living in San Francisco with HIV.

Information from www.sfgate.com

Related Videos
Jill Holdsworth, MS, CIC, FAPIC, CRCST, NREMT, CHL
Jill Holdsworth, MS, CIC, FAPIC, CRCSR, NREMT, CHL, and Katie Belski, BSHCA, CRCST, CHL, CIS
Baby visiting a pediatric facility  (Adobe Stock 448959249 by Rawpixel.com)
Antimicrobial Resistance (Adobe Stock unknown)
Anne Meneghetti, MD, speaking with Infection Control Today
Patient Safety: Infection Control Today's Trending Topic for March
Infection Control Today® (ICT®) talks with John Kimsey, vice president of processing optimization and customer success for Steris.
Picture at AORN’s International Surgical Conference & Expo 2024
Infection Control Today and Contagion are collaborating for Rare Disease Month.
Related Content